Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9030 Old Georgetown Road
221
Bethesda, MD 20892Phone+1 240-760-6036
Education & Training
University of Texas Medical Branch School of MedicinePh.D., Neuroscience, 2000
Capital University of Medical SciencesClass of 1993
Certifications & Licensure
MD State Medical License 2018 - 2025
NC State Medical License 2010 - 2018
OH State Medical License 2009 - 2011
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- NIH-Lasker Clinical Research Scholar Center for Cancer Research, National Cancer Institute, National Institutes of Health, 2018
- Paul Calabresi Clinical Oncology Scholar Award (K12 Career Award) NIH/NCI, 2011
- William James Miller Endowed Fellowship Award in Neuro-Oncology University of Texas MD Anderson Cancer Center, 2009
- Join now to see all
Clinical Trials
- Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy Start of enrollment: 2019 Oct 16
Roles: Principal Investigator, Contact
- Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype Start of enrollment: 2019 Mar 27
Roles: Contact, Principal Investigator
- Study of Zotiraciclib for Recurrent High-Grade Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations Start of enrollment: 2023 May 16
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Therapy enhancing chromosome instability may be advantageous forgliomas.Nikolay V Goncharov, Ivan N Baklanov, Valeriia S Gulaia, Anastasiia P Shuliak, Daria V Lanskikh
NAR Cancer. 2025-03-01 - The COVID-19 pandemic experience for patients with central nervous system tumors: Differences in patient-reported outcomes and practice recommendations.Amanda L King, Kayla N Roche, Elizabeth Vera, Valentina Pillai, Lily Polskin
Neuro-Oncology Practice. 2025-02-01 - Mitochondrial fatty acid oxidation regulates monocytic type I interferon signaling via histone acetylation.Jing Wu, Komudi Singh, Vivian Shing, Anand Gupta, Brett C Arenberg
Science Advances. 2025-01-24
Journal Articles
- Neoplastic MyelopathiesWu J and Ranjan S, Neurology Continuum (Spinal Cord Disorders), 1/1/2018
- Contemporary Murine Models in Preclinical Astrocytoma Drug DevelopmentMcNeill RS, Vitucci M, Wu J, Miller CR, Neuro-Oncology, 1/1/2015
Books/Book Chapters
Press Mentions
NCI-CONNECT and BTTC 2019 MeetingsJune 3rd, 2019
NIH Adds Eight Lasker Clinical Research ScholarsMarch 12th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
